Therapeutic options in juvenile idiopathic arthritis Surgical and conservative orthopedic rheumatological treatment

被引:1
|
作者
Haas, J. -P. [1 ]
Arbogast, M. [2 ]
机构
[1] Zentrum Schmerztherapie Junger Menschen, Deutsch Zentrum Kinder & Jugendrheumatol, Gehfeldstr 24, D-82467 Garmisch Partenkirchen, Germany
[2] Zentrum Rheumatol Orthopadie & Schmerztherapie Kl, Abt Rheumaorthopadie & Handchirurg, Oberammergau, Germany
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2021年 / 80卷 / 05期
关键词
Multidisciplinary treatment; Inflammatory activity; Remission; Pediatric rheumatology; Functional restoration;
D O I
10.1007/s00393-021-00996-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The treatment of juvenile idiopathic arthritis (JIA) has made substantial progress within the last 25 years. Modern medicinal treatment enables inflammatory activity of the disease to be controlled in most of the cases. Mutilating courses of disease, which were formerly the rule have now become the exception. Today remission of disease is the aim of pediatric rheumatological treatment. Apart from effective control of inflammation this includes complete restoration of functional abilities of affected joints and the surrounding structures also affected. To achieve this goal a holistic and foresighted view of each patient's course is required. Therefore, even in an apparently uncomplicated course of disease in some cases of JIA it is advisable to plan an early interdisciplinary consultation including the pediatric rheumatologist and the orthopedic surgeon, in order to discuss an early surgical intervention, which can then be carried out in a timely manner, if necessary. This article provides an overview of the orthopedic rheumatological indications and options.
引用
收藏
页码:467 / 480
页数:14
相关论文
共 50 条
  • [31] Treatment options in juvenile idiopathic arthritis. Part 2: Orthopedics und surgery
    Arbogast, M.
    Haas, J-P.
    ORTHOPADE, 2018, 47 (11): : 919 - 927
  • [32] Juvenile Idiopathic Arthritis Treatment Updates
    Onel, Karen
    Rumsey, Dax G.
    Shenoi, Susan
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2021, 47 (04) : 545 - 563
  • [33] Treatment of refractory juvenile idiopathic arthritis
    Wulffraat, NM
    Kuis, W
    JOURNAL OF RHEUMATOLOGY, 2001, 28 (05) : 929 - 931
  • [34] Treatment of systemic juvenile idiopathic arthritis
    Claas H. Hinze
    Dirk Foell
    Christoph Kessel
    Nature Reviews Rheumatology, 2023, 19 : 778 - 789
  • [35] Biologics for the Treatment of Juvenile Idiopathic Arthritis
    Poddighe, Dimitri
    Romano, Micol
    Gattinara, Maurizio
    Gerloni, Valeria
    CURRENT MEDICINAL CHEMISTRY, 2018, 25 (42) : 5860 - 5893
  • [36] Leflunomide treatment in juvenile idiopathic arthritis
    Ayaz, Nuray Aktay
    Karadag, Serife Gul
    Cakmak, Figen
    Cakan, Mustafa
    Tanatar, Ayse
    Sonmez, Hafize Emine
    RHEUMATOLOGY INTERNATIONAL, 2019, 39 (09) : 1615 - 1619
  • [37] Leflunomide treatment in juvenile idiopathic arthritis
    Nuray Aktay Ayaz
    Şerife Gül Karadağ
    Figen Çakmak
    Mustafa Çakan
    Ayşe Tanatar
    Hafize Emine Sönmez
    Rheumatology International, 2019, 39 : 1615 - 1619
  • [38] Treatment of systemic juvenile idiopathic arthritis
    Hinze, Claas H.
    Foell, Dirk
    Kessel, Christoph
    NATURE REVIEWS RHEUMATOLOGY, 2023, 19 (12) : 778 - 789
  • [39] Advances in the treatment of juvenile idiopathic arthritis
    Martini, Alberto
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2009, 27 (05) : 731 - 731
  • [40] The pharmacomedical treatment of juvenile idiopathic arthritis
    Weller, F
    Huppertz, HI
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2005, 64 (05): : 308 - 316